Abstract: In the context of evolving global drug policies, notable shifts have occurred, yet Asia persists as a region marked by stringent approaches to drug use and distribution. Analyzing recalcitrant jurisdictions offers insights into potential trajectories of global drug policy. Asia’s entrenched political and legal systems, resistant to harm reduction and human rights paradigms, wield substantial influence in shaping drug policy dialogues and reforms. This chapter provides an Asian drug policy overview, examining prevailing myths. Firstly, the causal link between historical trajectories and current reliance on prohibition is debunked. Secondly, the compatibility of criminal justice and harm reduction as complementary regulatory strategies is asserted, though transitioning remains intricate. Lastly, the pivotal role of human rights approaches in molding future Asian drug policy reform is underscored, refuting assertions of limited normative impact.
About the Working Paper Series:
The Harvard-Yenching Institute is pleased to make available working papers by HYI affiliated scholars on topics in the humanities and social sciences, with special attention to the study of Asian culture. The HYI Working Paper Series welcomes submissions from all HYI-affiliated faculty and fellowship grantees (including graduate students). Scholars are invited to post papers either in English or in an Asian language. To submit a paper, please email strogatz@fas.harvard.edu.
The views expressed in the HYI Working Paper Series are those of the author(s) and do not necessarily reflect those of the Harvard-Yenching Institute. HYI Working Papers have not undergone formal review and approval. Such papers are included in this series to elicit feedback and to encourage discussion. Copyright belongs to the author(s). Papers may be downloaded for personal use only, and may not be cited without the author’s permission.